⌘K

Login Start Free

Home/Filings/4/0001104659-23-021541

4//SEC Filing

Jin David 4

Accession 0001104659-23-021541

CIK 0001429260other

View on SEC.gov Company Profile

Filed

Feb 13, 7:00 PM ET

Accepted

Feb 14, 4:06 PM ET

Size

4.8 KB

Accession

0001104659-23-021541

Insider Transaction Report

Form 4

Period: 2023-02-10

Fortress Biotech, Inc.FBIO

Chief Financial Officer

Transactions

Purchase
COMMON STOCK, PAR VALUE $0.001
2023-02-10$0.83/sh+35,928$30,000→ 1,438,757 total

Footnotes (1)

[F1]The total holdings include 1,350,000 shares underlying deferred restricted stock units.

Documents

1 file

4
tm236803-1_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Fortress Biotech, Inc.

CIK 0001429260

Entity typeother

Related Parties

1

filerCIK 0001930732

Filing Metadata

Form type: 4
Filed: Feb 13, 7:00 PM ET
Accepted: Feb 14, 4:06 PM ET
Size: 4.8 KB

View on SEC.gov